AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 2 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $24.60
- 52-wk high
- $28.37
- High
- $24.84
- 52-wk low
- $18.85
- Low
- $24.46
- Prev close
- $24.43
- Mkt cap
- $82.05B
- P/E
- 9.6x
- Volume
- 3.02M
- Fwd P/E
- 7.2x
- Beta
- 0.87
- Div yield
- 0.47%
- P/S
- 2.9x
- P/B
- 0.8x
- Profit margin
- +27.9%
- Op margin
- +42.9%
- ROE
- +10.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about BCS filings
Are insiders buying or selling Barclays PLC ADR (BCS) stock?
Neither. Barclays PLC ADR (BCS) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded BCS recently?
None. No member of Congress disclosed a BCS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this BCS smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (1)
- JC
JPMorgan Chase
$29.5M
added
Sells/Trims (2)
- QR
Qube Research
$42.5M
trimmed
- JS
Jim Simons
$76.3M
trimmed
How top traders are positioned
No tracked top-trader positions in BCS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 1.1% above what analysts expected.
Earnings per share
$0.89 expected
Reports Oct 28, 2026, in 27 days
Estimates as of Sep 30, 2026
EPS expected
$0.71 to $0.71
Revenue expected
2 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 |
|---|---|
| What came in | |
| Revenue | $6.84B |
| Cost of what it sold | $456.4M |
| Gross profit | $6.38B |
| What it spent | |
| Sales and admin | $8.03B |
| Other operating costs | -$4.07B |
| Total operating expenses | $3.96B |
| What was left | |
| Operating profit | $2.42B |
| Profit before tax | $2.42B |
| Tax | $537.1M |
| Net profit | $1.86B |
| EBITDA | $2.42B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace